课题基金 / 基金详情

Multimorbidity clusters, trajectories and genetic risk, in British south Asians

Multimorbidity clusters, trajectories and genetic risk, in British south Asians
英国南亚人的多重发病集群、轨迹和遗传风险
批准号:
MR/S027297/1
负责人:
Sarah Finer
金额:
$64.43万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

Sarah Finer的其他基金

相似基金

相关文献

中文摘要
翻译
我们的研究方案涵盖了一个重要的健康领域,称为“多发病”,它描述了一个人在哪里受到两种或两种以上健康状况的影响。研究表明,多发性疾病在英国越来越常见,而英国国家医疗服务体系(NHS)目前没有旨在很好地解决这一问题的服务。最近的研究还表明,多发病存在于“聚集性”中,常见疾病(如2型糖尿病、高血压、慢性疼痛和抑郁症)组经常共存。然而,关于多发性疾病仍有许多需要了解,需要更多的研究来找出它发生的原因,谁处于危险之中,以及如何设计更好的健康和社会护理来管理它。我们的提议将产生新的知识,填补我们对多发性疾病理解的一些重要空白。我们将研究生活在伦敦东部105万人口中的多发性疾病的人群,其中三分之一来自南亚少数民族,生活在高度的社会经济贫困中;两者都是已知的多发性疾病的危险因素。在电子健康记录中收集的数据(例如,当您去看您的全科医生时向您作出的诊断或给予的治疗)将被用来告知我们该人群中的多发病情况。我们将使用最先进的统计技术,利用这些数据来告诉我们,在伦敦东部,哪些是最常见的多发性疾病,以及与白人相比,英国南亚人的多发病情况是否有所不同。利用历史记录,我们将研究一个人一生中的多病聚集性模式,哪些风险因素可能与它们相关,以及它们对个人的影响有多严重。我们研究的下一个重点将是使用对参与东伦敦基因与健康(ELGH)研究的志愿者的基因组的尖端研究来调查多病的遗传原因。Elgh是对生活在伦敦东部的英国-孟加拉国和巴基斯坦血统的人进行的一项大型研究,已经有3.2万名志愿者参与其中。Elgh的志愿者已经同意我们访问他们的电子健康记录,并使用捐赠给这项研究的唾液样本来研究他们的基因。我们将调查个体遗传密码的差异是否与多发性疾病的风险有关。我们将看到的一种特定的遗传密码变化被称为“同体合子”,这是一种影响这些种族群体中的一些人的现象,在这些种族中,父母关系很常见。自合性增加了一个人从父母那里继承的基因副本相同的可能性,一些研究表明这与某些疾病有关。我们将研究一个人的基因构成中的自合子数量是否会影响一个人患多发性疾病的风险。我们还将调查目前遗传和健康研究中一个主要感兴趣的领域,称为多基因风险评分(PR)。这些分数识别个体遗传密码的多个微小变化,当使用数学公式将这些变化加在一起时,可以强烈预测一个人是否有患心脏病等疾病的风险。PRSS主要是在白人群体中进行的研究,我们将为更广泛的努力做出贡献,调查它们对南亚人疾病和多发病的影响。我们的研究将为我们的研究使用潜在的敏感数据,我们将采取非常严格和谨慎的方法来使用这些数据,以便不存在数据安全问题,并确保使用适当的同意和信息治理程序收集所有数据。我们预计我们的研究将产生广泛的影响,包括支持改善多发性疾病的医疗和社会护理,也许还会更有效地使用有限的NHS资金。我们将通过教育方案和公众参与将直接利益回馈给我们的研究志愿者。
英文摘要
Our research proposal covers an important area of health called 'multimorbidity', which describes where an individual is affected by 2 or more health conditions. Studies have shown that multimorbidity is getting more common in the United Kingdom, and the National Health Service does (NHS) not currently have services designed to tackle it well. Recent research has also shown that multimorbidity exists in 'clusters', with groups of common conditions (e.g. type 2 diabetes, high blood pressure, chronic pain, and depression) often co-exist. However, there is a lot still to learn about multimorbidity, and more research is needed to find out why it occurs, who is at risk, and how to design better health and social care to manage it. Our proposal will produce new knowledge that fills some of the important gaps in our understanding of multimorbidity.We will study multimorbidity in people living in a large east London population of 1.05million people, one-third of whom come from a south Asian ethnic group and who live in high socioeconomic deprivation; both known to be risk factors for multimorbidity. Data collected in electronic health records (e.g. the diagnoses made or treatments given to you when you visit your GP) will be used to inform us about multimorbidity in this population. We will use state-of-the-art statistical techniques that use this data to tell us which are the most common 'clusters' of multimorbidity in east London, and whether they vary in British south Asians compared to Whites. Using historical records, we will study patterns of multimorbidity clusters during a person's life, what risk factors might be associated with them, and how severely they may impact an individual.The next focus in our research will be to investigate the genetic causes of multimorbidity using cutting edge studies of the genome in volunteers participating in the East London Genes and Health (ELGH) study. ELGH is a large study of people of British-Bangladeshi and -Pakistani origin living in east London, with 32,000 volunteers involved already. Volunteers in ELGH have given consent for us to access their electronic health records and also study their genes using a spit sample donated to the study. We will investigate whether differences in the genetic code of individuals are linked to the risk of multimorbidity. One specific genetic code change we will be looking at is called 'autozygosity', a phenomenon affecting some people in these ethnic groups where parental relatedness is common. Autozygosity increases the chance that gene copies inherited from a person's mother and father are the same, and some studies have shown that this is linked to certain disease. We will study whether the amount of autozygosity in a person's genetic make-up could affect a person's risk of developing multimorbidity. We will also investigate an area of major interest in genetic and health studies at the moment, called polygenic risk scores (PRS). These scores identify multiple, small changes to an individual's genetic code that, when added together using a mathematical formula, strongly predict whether someone is at risk of developing conditions such as heart disease. PRSs have been studied mostly in people of White ethnic groups, and we will contribute to wider efforts to investigate their impact on disease and multimorbidity in south Asians. Our research will use potentially sensitive data for our studies and we will take very stringent and careful approaches to using this data so that there are no data security issues, and to ensure all data has been collected using appropriate consent and information governance procedures.We expect that the impact of our research will be wide-ranging, including supporting improvements in health and social care for multimorbidity and perhaps more efficient use of limited NHS funds. We will deliver direct benefits back to our research volunteers through educational programmes and public engagement.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Tracking trajectories of multiple long-term conditions using dynamic patient-cluster associations
使用动态患者集群关联跟踪多种长期病症的轨迹
DOI: 10.1109/bigdata55660.2022.10021034
发表时间: 2022
期刊:
影响因子: --
作者: [Kremer R]
通讯作者: Kremer R
DOI: 10.1016/j.cell.2023.08.028
发表时间: 2023-10-12
期刊: CELL
影响因子: 64.5
作者: [Malawsky, Daniel S., van Walree, Eva, Jacobs, Benjamin M., Heng, Teng Hiang, Huang, Qin Qin, Sabir, Ataf H., Rahman, Saadia, Sharif, Saghira Malik, Khan, Ahsan, Mirkov, Masa Umicevic, Kuwahara, Hiroyuki, Gao, Xin, Alkuraya, Fowzan S., Posthuma, Danielle, Newman, William G., Griffiths, Christopher J., Mathur, Rohini, van Heel, David A., Finer, Sarah, O'Connell, Jared, Martin, Hilary C.]
通讯作者: Martin, Hilary C.
DOI: 10.1038/s41467-022-32095-5
发表时间: 2022-08-09
期刊: Nature communications
影响因子: 16.6
作者: []
通讯作者:
Influence of autozygosity on common disease risk across the phenotypic spectrum
自合性对整个表型谱中常见疾病风险的影响
DOI: 10.1101/2023.02.01.23285346
发表时间: 2023
期刊:
影响因子: --
作者: [Malawsky D]
通讯作者: Malawsky D
Genes & Health Longitudinal Population Study
  • 批准号:
    MR/X009920/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $259.05万
  • 财政年份:
    2023
  • 负责人:
    Sarah Finer
  • 依托单位:
Does abnormal one-carbon metabolism or hyperglycaemia in utero cause epigenetic change and fetal programming of cardiome
  • 批准号:
    G0800441/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $28.96万
  • 财政年份:
    2008
  • 负责人:
    Sarah Finer
  • 依托单位:
国内基金
海外基金
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
  • 批准号:
    82371997
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张春富
  • 依托单位:
星系结构基本单元星团的研究
  • 批准号:
    11043006
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    理查德迪何瑞斯
  • 依托单位:
The formation and evolution of planetary systems in dense star clusters
  • 批准号:
    11043007
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    柯文采
  • 依托单位:
星系演化背景下的年轻超大质量星团:悬而未决的难题
  • 批准号:
    11073001
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2010
  • 负责人:
    理查德·迪何瑞斯
  • 依托单位: